Ready-to-use, fast, consistent, and automated algorithm
An intelligent and advanced digital pathology solution requires artificial intelligence-based image analysis tools that empower pathologists to confidently and objectively assess whole tissue slide images.
The uPath HER2 Dual ISH image analysis, Breast algorithm is an adjunctive computer-assisted tool that enumerates HER2 and Chromosome 17 signals to determine HER2 gene status within a pathologist-annotated viable tumor region in images of formalin-fixed, paraffin-embedded neoplastic breast tissue.
Validated for use with the VENTANA HER2 Dual ISH assay and Roche uPath enterprise software/ navify Digital Pathology.
Pathologist-trained image analysis algorithm quickly calculates HER2/Chr17 ratio.
Actionable assessment of scanned slide images that are objective and reproducible.
A heatmap guides pathologists to areas suitable for scoring based on an increase of HER2 signals relative to Chr17 signals.
A clear visual overlay highlights socrable cells and identifies representative cells used to calculate HER2/Chr17 in red.
The ROI panel allows pathologists to select identified cells and see the corresponding number of HER2 and Chr17 signals.
The Roche Digital Pathology solution comprises high-performance hardware, software and uPath whole slide image analysis algorithms, and works in integrated harmony with the full Roche diagnostic portfolio for an end-to-end experience that enhances pathology workflows.
*CE-IVD marked. For Research Use Only in the US. Not for use in diagnostic procedures in the US.
Refer to the product-specific labeling for the regulatory status of the scanner and uPath. When Research Use Only products are used with IVD products, the integrated workflow will be for Research Use Only and cannot be used for diagnostic procedures.